Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2020 - 2026)

Aurinia Pharmaceuticals has reported Other Working Capital Changes for 7 years, with the latest figure at -$214000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 96.45% year-over-year to -$214000.0; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (up 385.24% YoY), and the FY2025 full-year result was $3.7 million, up 100.0% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$214000.0, down from $4.6 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $11.2 million in Q2 2025, with the low at -$6.1 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged $673823.5 across 5 years, with a median of $94000.0 in 2024.
• The largest YoY upside for Other Working Capital Changes was 4782.1% in 2025 against a maximum downside of 6575.53% in 2025.
• Aurinia Pharmaceuticals' Other Working Capital Changes stood at -$1.1 million in 2022, then surged by 182.69% to $874000.0 in 2023, then surged by 172.77% to $2.4 million in 2024, then soared by 93.29% to $4.6 million in 2025, then sank by 104.64% to -$214000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$214000.0 (Q1 2026), $4.6 million (Q4 2025), and -$6.1 million (Q3 2025), per Business Quant data.